# Privia Health to Report First Quarter 2026 Results on Thursday, May 7
Canonical URL: https://biopharmsignal.com/news/PRVA/privia-health-to-report-first-quarter-2026-results-on-thursday-may-7
Ticker: PRVA
Company: Privia Health
Source: Privia Health
Published: 2026-04-08 13:00 EST
Original Source URL: https://ir.priviahealth.com
## Summary

ARLINGTON, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2026 before market open on Thursday, May 7, 2026. The press release is expected to be publicly disseminated

## Article Body
ARLINGTON, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2026 before market open on Thursday, May 7, 2026. The press release is expected to be publicly disseminated
## Recent Company News
- 2026-05-27 13:00 EST — [Privia Health Enters New Jersey](https://biopharmsignal.com/news/PRVA/privia-health-enters-new-jersey) — Source: Privia Health
- 2026-05-07 10:00 EST — [Privia Health Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/PRVA/privia-health-reports-first-quarter-2026-financial-results) — Source: Privia Health
- 2026-04-08 13:00 EST — [Privia Health to Report First Quarter 2026 Results on Thursday, May 7](https://biopharmsignal.com/news/PRVA/privia-health-to-report-first-quarter-2026-results-on-thursday-may-7) — Source: Privia Health
- 2026-03-24 13:00 EST — [Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence](https://biopharmsignal.com/news/PRVA/privia-health-earns-2026-hfma-map-award-for-revenue-cycle-excellence) — Source: Privia Health
- 2026-02-26 11:00 EST — [Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results](https://biopharmsignal.com/news/PRVA/privia-health-reports-fourth-quarter-and-full-year-2025-financial-results) — Source: Privia Health
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)